Literature DB >> 845254

Denatured hemoglobin in sickle erythrocytes.

T Asakura, K Minakata, K Adachi, M O Russell, E Schwartz.   

Abstract

To study the nature of numerous inclusion bodies seen in red cells from patients with sickle cell disease (Hb SS), we have prepared red cell ghosts free of oxyhemoglobin and analyzed them by spectrophotometric and heme extraction methods. The absorption spectrum in the visible region of the ghost suspensions was typical of hemichromes. The spectrum was similar to that of denatured hemoglobin repared by treatment of oxyhemoglobin S with mechanical shaking or heat. Similar treatment of cells containing only normal hemoglobin (Hb AA) showed a very small amount of denatured hemoglobin, approximately one-fifth of the amount in Hb SS cells. The amount of denatured hemoglobin determined after solution of membrane with 2.5% sodium dodecyl sulfate was 0.158+/-0.070% (1 SD) of the total cellular heme in Hb SS patients. In controls, the amount was 0.030+/-0.016%. Persons with Hb AA and reticulocytosis did not have an elevated amount of membrane-associated heme. In patients with hereditary spherocytosis and autoimmune hemolytic anemia, denatured stromal hemoglobin was normal or slightly elevated before and after splenectomy. The increased amount of denatured hemoglobin in Hb SS red cells may be related to the instability of sickle oxyhemoglobin.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 845254      PMCID: PMC372267          DOI: 10.1172/JCI108681

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  14 in total

1.  The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes.

Authors:  J T DODGE; C MITCHELL; D J HANAHAN
Journal:  Arch Biochem Biophys       Date:  1963-01       Impact factor: 4.013

2.  Oxidative hemolysis and precipitation of hemoglobin. I. Heinz body anemias as an acceleration of red cell aging.

Authors:  J H JANDL; L K ENGLE; D W ALLEN
Journal:  J Clin Invest       Date:  1960-12       Impact factor: 14.808

3.  Electrophoretic components of the hemoglobin of red cell membranes.

Authors:  F A KLIPSTEIN; H M RANNEY
Journal:  J Clin Invest       Date:  1960-12       Impact factor: 14.808

4.  Relation of hemoglobin to the red cell membrane.

Authors:  H M ANDERSON; J C TURNER
Journal:  J Clin Invest       Date:  1960-01       Impact factor: 14.808

5.  Mechanical instability of the oxy-form of sickle haemoglobin.

Authors:  T Asakura; P L Agarwal; D A Relman; J A McCray; B Chance; E Schwartz; S Friedman; B Lubin
Journal:  Nature       Date:  1973-08-17       Impact factor: 49.962

6.  Intraerythrocytic precipitations of haemoglobins S and C.

Authors:  R G Schneider; I Takeda; L P Gustavson; J B Alperin
Journal:  Nat New Biol       Date:  1972-01-19

Review 7.  Denaturation of the normal and abnormal hemoglobin molecule.

Authors:  E A Rachmilewitz
Journal:  Semin Hematol       Date:  1974-10       Impact factor: 3.851

8.  Studies on the stability of oxyhemoglobin A and its constituent chains and their derivatives.

Authors:  E A Rachmilewitz; J Peisach; W E Blumberg
Journal:  J Biol Chem       Date:  1971-05-25       Impact factor: 5.157

9.  Role of haemichromes in the formation of inclusion bodies in haemoglobin H disease.

Authors:  E A Rachmilewitz; J Peisach; T B Bradley; W E Blumberg
Journal:  Nature       Date:  1969-04-19       Impact factor: 49.962

10.  Abnormal precipitation of oxyhemoglobin S by mechanical shaking.

Authors:  T Asakura; T Onishi; S Friedman; E Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1974-05       Impact factor: 11.205

View more
  21 in total

1.  Detection, characterization, and bioavailability of membrane-associated iron in the intact sickle red cell.

Authors:  T Sugihara; T Repka; R P Hebbel
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

2.  Accelerated denaturation of hemoglobin and the antimalarial action of chloroquine.

Authors:  Coy D Fitch; Natrice V Russell
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

3.  Thalassemic erythrocytes release microparticles loaded with hemichromes by redox activation of p72Syk kinase.

Authors:  Emanuela Ferru; Antonella Pantaleo; Franco Carta; Franca Mannu; Amina Khadjavi; Valentina Gallo; Luisa Ronzoni; Giovanna Graziadei; Maria Domenica Cappellini; Francesco Turrini
Journal:  Haematologica       Date:  2013-09-13       Impact factor: 9.941

4.  Erythrocytes inhibit ligament fibroblast proliferation in a collagen scaffold.

Authors:  Sophia L Harrison; Patrick Vavken; Martha M Murray
Journal:  J Orthop Res       Date:  2011-03-28       Impact factor: 3.494

5.  Accelerated autoxidation and heme loss due to instability of sickle hemoglobin.

Authors:  R P Hebbel; W T Morgan; J W Eaton; B E Hedlund
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

6.  Quantitative studies of ferritinlike iron in erythrocytes of thalassemia, sickle-cell anemia, and hemoglobin Hammersmith with Mössbauer spectroscopy.

Authors:  E R Bauminger; S G Cohen; S Ofer; E A Rachmilewitz
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

7.  Spontaneous oxygen radical generation by sickle erythrocytes.

Authors:  R P Hebbel; J W Eaton; M Balasingam; M H Steinberg
Journal:  J Clin Invest       Date:  1982-12       Impact factor: 14.808

8.  Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: possible mechanism for microvascular occlusion in sickle cell disease.

Authors:  R P Hebbel; O Yamada; C F Moldow; H S Jacob; J G White; J W Eaton
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

9.  High-voltage electron microscopy of normal and irreversibly sickled red blood cells.

Authors:  G E Wise; E Miller; C M Castello
Journal:  Cell Tissue Res       Date:  1981       Impact factor: 5.249

10.  Abnormalities in membrane phospholipid organization in sickled erythrocytes.

Authors:  B Lubin; D Chiu; J Bastacky; B Roelofsen; L L Van Deenen
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.